Risk Adapted Management of Febrile Neutrepenia and Early Cessation of Empirical Antibiotherapy in Hematopoietic Stem Cell Transplantation Setting.
about
Risk Adapted Management of Febrile Neutrepenia and Early Cessation of Empirical Antibiotherapy in Hematopoietic Stem Cell Transplantation Setting.
description
2017 nî lūn-bûn
@nan
2017 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Risk Adapted Management of Feb ...... Cell Transplantation Setting.
@ast
Risk Adapted Management of Feb ...... Cell Transplantation Setting.
@en
Risk Adapted Management of Feb ...... Cell Transplantation Setting.
@nl
type
label
Risk Adapted Management of Feb ...... Cell Transplantation Setting.
@ast
Risk Adapted Management of Feb ...... Cell Transplantation Setting.
@en
Risk Adapted Management of Feb ...... Cell Transplantation Setting.
@nl
prefLabel
Risk Adapted Management of Feb ...... Cell Transplantation Setting.
@ast
Risk Adapted Management of Feb ...... Cell Transplantation Setting.
@en
Risk Adapted Management of Feb ...... Cell Transplantation Setting.
@nl
P2093
P2860
P1476
Risk Adapted Management of Feb ...... Cell Transplantation Setting.
@en
P2093
Ali Hakan Kaya
Bahar Ulu Uncu
Dicle Koca
Emre Tekgündüz
Fazilet Duygu
Fevzi Altuntaş
Filiz Bekdemir
Hikmetullah Batgi
Mehmet Sinan Dal
Merih Çakar Kızıl
P2860
P304
P356
10.4274/BALKANMEDJ.2016.0012
P577
2017-04-01T00:00:00Z